How responses to the 2020 pandemic could underpin accelerated improvements in patient care

Dr. Sarah Hardison, PhD

Head of Product,
Regulatory & PV

Clarivate

Michael Ward

Global Head of
Thought leadership

Clarivate

In 2020, the life sciences sector mobilized at unprecedented speed to tackle the most significant health crisis facing humanity in a century. Researchers, industry and regulators collaborated to harness innovative science with some creative deal structures to develop treatments and vaccines in record time, clinicians adopted new approaches to consult and treat patients, greater sums of money, from both public and private sources, have been invested to finance these efforts. Clarivate’s Sarah Hardison and Mike Ward will discuss what lessons can be learnt that could accelerate the development of treatments for other major diseases and improve patient care.